Androgen receptor–cofactor interactions as targets for new drug discovery
- 1 May 2005
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 26 (5) , 225-228
- https://doi.org/10.1016/j.tips.2005.03.002
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Mining the Complexities of the Estrogen Signaling Pathways for Novel TherapeuticsEndocrinology, 2003
- The Use of Phage Display Technique for the Isolation of Androgen Receptor Interacting Peptides with (F/W)XXL(F/W) and FXXLY New Signature MotifsJournal of Biological Chemistry, 2003
- Evaluation of Ligand-Dependent Changes in AR Structure Using Peptide ProbesMolecular Endocrinology, 2002
- Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosteroneProceedings of the National Academy of Sciences, 2001
- Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen ReceptorJournal of Biological Chemistry, 2000
- FXXLF and WXXLF Sequences Mediate the NH2-terminal Interaction with the Ligand Binding Domain of the Androgen ReceptorJournal of Biological Chemistry, 2000
- The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by TamoxifenPublished by Elsevier ,1998
- Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γNature, 1998
- A signature motif in transcriptional co-activators mediates binding to nuclear receptorsNature, 1997